modernretina2d
A new technique to estimate melanocytic choroidal tumor thicknesses without B-scan ultrasonography
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
modernretina2d
Opthea to present data from Phase 2b trial of sozinibercept at the Macula Society 48th Annual Meeting
In his presentation, David S. Boyer, MD will present data from the sozinibercept Phase 2b wet AMD trial which demonstrated that superior vision and anatomic outcomes were observed with sozinibercept 2 ...
modernretina3d
OCT biomarkers predictive of vision changes in nAMD
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
modernretina4d
Axovia Therapeutics receives grant from A Race Against Blindness to support upcoming clinical trial
The trial will feature the company’s product candidate, AXV101, focused on combating childhood blindness due to retinitis pigmentosa (RP) caused by Bardet-Biedl Syndrome 1 (BBS1). In December 2024, a ...
modernretina5d
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
modernretina5d
4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study
PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal ...